The WACC of E-Therapeutics PLC (ETX.L) is 7.6%.
| Range | Selected | |
| Cost of equity | 6.50% - 8.80% | 7.65% |
| Tax rate | 16.70% - 17.90% | 17.30% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 6.4% - 8.7% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.41 | 0.54 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.50% | 8.80% |
| Tax rate | 16.70% | 17.90% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 6.4% | 8.7% |
| Selected WACC | 7.6% | |